Intrinsic value of Teleflex - TFX

Previous Close

$204.35

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$204.35

 
Intrinsic value premium content
 
Up/down potential premium content
 
Rating premium content
 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of TFX stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 9.1

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  3.20
  6.00
  5.90
  5.81
  5.73
  5.66
  5.59
  5.53
  5.48
  5.43
  5.39
  5.35
  5.31
  5.28
  5.25
  5.23
  5.21
  5.19
  5.17
  5.15
  5.14
  5.12
  5.11
  5.10
  5.09
  5.08
  5.07
  5.06
  5.06
  5.05
  5.05
Revenue, $m
  1,868
  1,980
  2,097
  2,219
  2,346
  2,479
  2,617
  2,762
  2,913
  3,071
  3,237
  3,410
  3,591
  3,781
  3,979
  4,188
  4,406
  4,634
  4,873
  5,124
  5,388
  5,664
  5,953
  6,256
  6,575
  6,909
  7,259
  7,627
  8,013
  8,417
  8,842
Variable operating expenses, $m
 
  1,638
  1,727
  1,820
  1,917
  2,018
  2,124
  2,234
  2,349
  2,470
  2,596
  2,601
  2,739
  2,883
  3,035
  3,194
  3,360
  3,534
  3,717
  3,908
  4,109
  4,319
  4,540
  4,771
  5,014
  5,269
  5,536
  5,816
  6,111
  6,419
  6,743
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  1,568
  1,638
  1,727
  1,820
  1,917
  2,018
  2,124
  2,234
  2,349
  2,470
  2,596
  2,601
  2,739
  2,883
  3,035
  3,194
  3,360
  3,534
  3,717
  3,908
  4,109
  4,319
  4,540
  4,771
  5,014
  5,269
  5,536
  5,816
  6,111
  6,419
  6,743
Operating income, $m
  300
  342
  370
  399
  429
  461
  493
  528
  564
  601
  641
  809
  852
  897
  945
  994
  1,046
  1,100
  1,157
  1,216
  1,279
  1,344
  1,413
  1,485
  1,561
  1,640
  1,723
  1,810
  1,902
  1,998
  2,099
EBITDA, $m
  417
  536
  568
  601
  635
  671
  708
  748
  788
  831
  876
  923
  972
  1,023
  1,077
  1,133
  1,192
  1,254
  1,319
  1,387
  1,458
  1,533
  1,611
  1,693
  1,779
  1,870
  1,965
  2,064
  2,169
  2,278
  2,393
Interest expense (income), $m
  44
  36
  40
  44
  48
  53
  57
  62
  67
  73
  78
  84
  90
  97
  103
  110
  118
  125
  133
  142
  151
  160
  170
  180
  191
  202
  214
  226
  239
  253
  267
Earnings before tax, $m
  246
  307
  330
  355
  381
  408
  436
  466
  496
  529
  562
  725
  762
  801
  841
  884
  928
  975
  1,023
  1,075
  1,128
  1,184
  1,243
  1,305
  1,370
  1,438
  1,509
  1,584
  1,663
  1,745
  1,832
Tax expense, $m
  8
  83
  89
  96
  103
  110
  118
  126
  134
  143
  152
  196
  206
  216
  227
  239
  251
  263
  276
  290
  305
  320
  336
  352
  370
  388
  408
  428
  449
  471
  495
Net income, $m
  237
  224
  241
  259
  278
  298
  318
  340
  362
  386
  411
  529
  556
  585
  614
  645
  678
  711
  747
  784
  824
  865
  908
  953
  1,000
  1,050
  1,102
  1,157
  1,214
  1,274
  1,337

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  544
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  3,891
  3,549
  3,758
  3,976
  4,204
  4,442
  4,690
  4,950
  5,221
  5,504
  5,801
  6,111
  6,436
  6,776
  7,132
  7,505
  7,895
  8,305
  8,734
  9,184
  9,655
  10,150
  10,668
  11,212
  11,783
  12,381
  13,009
  13,668
  14,359
  15,085
  15,846
Adjusted assets (=assets-cash), $m
  3,347
  3,549
  3,758
  3,976
  4,204
  4,442
  4,690
  4,950
  5,221
  5,504
  5,801
  6,111
  6,436
  6,776
  7,132
  7,505
  7,895
  8,305
  8,734
  9,184
  9,655
  10,150
  10,668
  11,212
  11,783
  12,381
  13,009
  13,668
  14,359
  15,085
  15,846
Revenue / Adjusted assets
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
  0.558
Average production assets, $m
  1,456
  1,542
  1,633
  1,728
  1,827
  1,931
  2,039
  2,151
  2,269
  2,393
  2,521
  2,656
  2,798
  2,945
  3,100
  3,262
  3,432
  3,610
  3,796
  3,992
  4,197
  4,412
  4,637
  4,874
  5,122
  5,382
  5,655
  5,941
  6,242
  6,557
  6,888
Working capital, $m
  755
  418
  442
  468
  495
  523
  552
  583
  615
  648
  683
  719
  758
  798
  840
  884
  930
  978
  1,028
  1,081
  1,137
  1,195
  1,256
  1,320
  1,387
  1,458
  1,532
  1,609
  1,691
  1,776
  1,866
Total debt, $m
  1,033
  945
  1,043
  1,146
  1,253
  1,364
  1,481
  1,602
  1,730
  1,862
  2,002
  2,147
  2,299
  2,459
  2,626
  2,801
  2,984
  3,176
  3,377
  3,588
  3,809
  4,041
  4,284
  4,540
  4,807
  5,088
  5,382
  5,691
  6,016
  6,356
  6,713
Total liabilities, $m
  1,752
  1,664
  1,762
  1,865
  1,972
  2,083
  2,200
  2,321
  2,449
  2,581
  2,721
  2,866
  3,018
  3,178
  3,345
  3,520
  3,703
  3,895
  4,096
  4,307
  4,528
  4,760
  5,003
  5,259
  5,526
  5,807
  6,101
  6,410
  6,735
  7,075
  7,432
Total equity, $m
  2,139
  1,884
  1,995
  2,111
  2,232
  2,359
  2,490
  2,628
  2,772
  2,923
  3,080
  3,245
  3,417
  3,598
  3,787
  3,985
  4,192
  4,410
  4,638
  4,876
  5,127
  5,389
  5,665
  5,954
  6,257
  6,574
  6,908
  7,258
  7,625
  8,010
  8,414
Total liabilities and equity, $m
  3,891
  3,548
  3,757
  3,976
  4,204
  4,442
  4,690
  4,949
  5,221
  5,504
  5,801
  6,111
  6,435
  6,776
  7,132
  7,505
  7,895
  8,305
  8,734
  9,183
  9,655
  10,149
  10,668
  11,213
  11,783
  12,381
  13,009
  13,668
  14,360
  15,085
  15,846
Debt-to-equity ratio
  0.483
  0.500
  0.520
  0.540
  0.560
  0.580
  0.590
  0.610
  0.620
  0.640
  0.650
  0.660
  0.670
  0.680
  0.690
  0.700
  0.710
  0.720
  0.730
  0.740
  0.740
  0.750
  0.760
  0.760
  0.770
  0.770
  0.780
  0.780
  0.790
  0.790
  0.800
Adjusted equity ratio
  0.477
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531
  0.531

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  237
  224
  241
  259
  278
  298
  318
  340
  362
  386
  411
  529
  556
  585
  614
  645
  678
  711
  747
  784
  824
  865
  908
  953
  1,000
  1,050
  1,102
  1,157
  1,214
  1,274
  1,337
Depreciation, amort., depletion, $m
  117
  194
  198
  202
  206
  210
  215
  220
  225
  230
  235
  114
  120
  126
  132
  139
  147
  154
  162
  171
  179
  189
  198
  208
  219
  230
  242
  254
  267
  280
  294
Funds from operations, $m
  427
  417
  439
  461
  484
  508
  533
  560
  587
  616
  646
  643
  676
  710
  747
  784
  824
  866
  909
  955
  1,003
  1,053
  1,106
  1,161
  1,219
  1,280
  1,343
  1,410
  1,481
  1,554
  1,632
Change in working capital, $m
  19
  24
  25
  26
  27
  28
  29
  31
  32
  33
  35
  37
  38
  40
  42
  44
  46
  48
  51
  53
  56
  58
  61
  64
  67
  70
  74
  78
  81
  85
  90
Cash from operations, $m
  408
  333
  414
  435
  457
  480
  504
  529
  555
  583
  611
  606
  638
  670
  705
  741
  778
  818
  859
  902
  947
  995
  1,045
  1,097
  1,152
  1,209
  1,270
  1,333
  1,399
  1,469
  1,542
Maintenance CAPEX, $m
  0
  -62
  -66
  -70
  -74
  -78
  -83
  -87
  -92
  -97
  -102
  -108
  -114
  -120
  -126
  -132
  -139
  -147
  -154
  -162
  -171
  -179
  -189
  -198
  -208
  -219
  -230
  -242
  -254
  -267
  -280
New CAPEX, $m
  -53
  -87
  -91
  -95
  -99
  -103
  -108
  -113
  -118
  -123
  -129
  -135
  -141
  -148
  -155
  -162
  -170
  -178
  -187
  -196
  -205
  -215
  -225
  -236
  -248
  -260
  -273
  -286
  -301
  -315
  -331
Cash from investing activities, $m
  -57
  -149
  -157
  -165
  -173
  -181
  -191
  -200
  -210
  -220
  -231
  -243
  -255
  -268
  -281
  -294
  -309
  -325
  -341
  -358
  -376
  -394
  -414
  -434
  -456
  -479
  -503
  -528
  -555
  -582
  -611
Free cash flow, $m
  351
  184
  257
  270
  284
  299
  314
  329
  345
  362
  380
  364
  383
  403
  424
  446
  469
  493
  518
  544
  572
  601
  631
  662
  695
  730
  767
  805
  845
  887
  931
Issuance/(repayment) of debt, $m
  -43
  95
  98
  102
  107
  112
  116
  122
  127
  133
  139
  146
  152
  159
  167
  175
  183
  192
  201
  211
  221
  232
  243
  255
  268
  281
  295
  309
  324
  340
  357
Issuance/(repurchase) of shares, $m
  9
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -60
  95
  98
  102
  107
  112
  116
  122
  127
  133
  139
  146
  152
  159
  167
  175
  183
  192
  201
  211
  221
  232
  243
  255
  268
  281
  295
  309
  324
  340
  357
Total cash flow (excl. dividends), $m
  264
  279
  355
  373
  391
  410
  430
  451
  473
  495
  519
  509
  535
  563
  591
  621
  652
  685
  719
  755
  793
  832
  874
  917
  963
  1,011
  1,061
  1,114
  1,169
  1,227
  1,288
Retained Cash Flow (-), $m
  -130
  -106
  -111
  -116
  -121
  -126
  -132
  -138
  -144
  -151
  -157
  -165
  -172
  -181
  -189
  -198
  -207
  -217
  -228
  -239
  -250
  -263
  -275
  -289
  -303
  -318
  -333
  -350
  -367
  -385
  -404
Prev. year cash balance distribution, $m
 
  361
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  534
  244
  257
  270
  284
  298
  313
  329
  345
  362
  345
  363
  382
  402
  423
  445
  468
  491
  516
  543
  570
  599
  629
  660
  693
  728
  764
  802
  842
  884
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  512
  223
  224
  222
  220
  216
  211
  205
  198
  190
  164
  155
  145
  135
  124
  113
  102
  90
  80
  69
  59
  50
  41
  34
  27
  21
  16
  12
  9
  7
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products consisting of Arrow branded catheters and related devices for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and withdrawal of blood samples; interventional access products that are used in dialysis, oncology, and critical care therapies; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. The company also provides surgical products, such as ligating clips and fascial closure systems; bladeless access ports, sutures, and other surgical instruments; and single-use and reusable products for surgical procedures under the Deknatel, Pilling, Kmedic, Hem-o-lok, and Weck brands. In addition, it offers medical devices for use in critical care, surgical, and cardiac care applications; and respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand. Further, the company provides cardiac care products comprising diagnostic catheters; specialized catheters; therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Additionally, it provides catheters, urine collectors, catheterization accessories, and products for operative endourology under the Rusch brand name; micro-laparoscopic instrumentation products; and original equipment manufacturing services. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

FINANCIAL RATIOS  of  Teleflex (TFX)

Valuation Ratios
P/E Ratio 38
Price to Sales 4.8
Price to Book 4.2
Price to Tangible Book
Price to Cash Flow 22.1
Price to Free Cash Flow 25.4
Growth Rates
Sales Growth Rate 3.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -13.1%
Cap. Spend. - 3 Yr. Gr. Rate -3.7%
Financial Strength
Quick Ratio 3
Current Ratio 0
LT Debt to Equity 39.7%
Total Debt to Equity 48.3%
Interest Coverage 7
Management Effectiveness
Return On Assets 7.2%
Ret/ On Assets - 3 Yr. Avg. 6.8%
Return On Total Capital 7.6%
Ret/ On T. Cap. - 3 Yr. Avg. 7.3%
Return On Equity 11.4%
Return On Equity - 3 Yr. Avg. 11.3%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 53.3%
Gross Margin - 3 Yr. Avg. 52.2%
EBITDA Margin 21.8%
EBITDA Margin - 3 Yr. Avg. 21.5%
Operating Margin 16.1%
Oper. Margin - 3 Yr. Avg. 16.2%
Pre-Tax Margin 13.2%
Pre-Tax Margin - 3 Yr. Avg. 12.9%
Net Profit Margin 12.7%
Net Profit Margin - 3 Yr. Avg. 12.1%
Effective Tax Rate 3.3%
Eff/ Tax Rate - 3 Yr. Avg. 6.6%
Payout Ratio 24.9%

TFX stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the TFX stock intrinsic value calculation we used $1868 million for the last fiscal year's total revenue generated by Teleflex. The default revenue input number comes from 2016 income statement of Teleflex. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our TFX stock valuation model: a) initial revenue growth rate of 6% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for TFX is calculated based on our internal credit rating of Teleflex, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Teleflex.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of TFX stock the variable cost ratio is equal to 83.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for TFX stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 4.2% for Teleflex.

Corporate tax rate of 27% is the nominal tax rate for Teleflex. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the TFX stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for TFX are equal to 77.9%.

Life of production assets of 23.4 years is the average useful life of capital assets used in Teleflex operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for TFX is equal to 21.1%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2139 million for Teleflex - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 44.52 million for Teleflex is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Teleflex at the current share price and the inputted number of shares is $9.1 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
BCR C.R. Bard 315.98 prem.  prem.
BDX Becton Dickins 195.06 prem.  prem.
MMSI Merit Medical 37.10 prem.  prem.
ANGO AngioDynamics 16.42 prem.  prem.
HYH Halyard Health 38.88 prem.  prem.
JNJ Johnson&Johnso 136.05 prem.  prem.

COMPANY NEWS

▶ ETFs with exposure to Teleflex, Inc. : June 20, 2017   [Jun-20-17 03:19PM  Capital Cube]
▶ Eaton Vance Worldwide Health Sciences Fund Adds 4 Companies   [May-17-17 04:30PM  GuruFocus.com]
▶ Teleflex, Inc. Value Analysis (NYSE:TFX) : May 11, 2017   [May-11-17 07:40PM  Capital Cube]
▶ Teleflex Announces Quarterly Dividend   [06:30AM  Business Wire]
▶ Teleflex beats Street 1Q forecasts   [May-04-17 06:50AM  Associated Press]
▶ Teleflex Reports First Quarter 2017 Results   [06:30AM  Business Wire]
▶ Teleflex Introduces the AsthmaMDTM Peak Flow Meter   [Apr-20-17 06:45AM  Business Wire]
▶ Teleflex Completes Acquisition of Pyng Medical Corp.   [Apr-03-17 05:30PM  Business Wire]
▶ Teleflex's Arrow operations in Asheboro continue layoffs   [Mar-27-17 08:43AM  at bizjournals.com]
▶ Teleflex's Arrow operations in Asheboro continue layoffs   [08:43AM  American City Business Journals]
▶ Moving Average Crossover Alert: Teleflex (TFX)   [Mar-13-17 06:33AM  Zacks]
▶ Teleflex Announces Quarterly Dividend   [06:45AM  Business Wire]
▶ [$$] Mario Gabelli's Latest Big Buy: Vascular Solutions   [Feb-03-17 07:52AM  at Barrons.com]
▶ Large layoffs skyrocket in North Carolina in 2016   [Jan-03-17 10:54AM  at bizjournals.com]
▶ Should You Avoid Everest Re Group Ltd (RE)?   [09:26AM  at Insider Monkey]
▶ Investors Are Clamoring For Teleflex Incorporated (TFX)   [Nov-26-16 01:57PM  at Insider Monkey]
▶ Teleflex Announces Quarterly Dividend   [06:45AM  Business Wire]
▶ Teleflex Reports Third Quarter 2016 Results   [06:30AM  Business Wire]
Stock chart of TFX Financial statements of TFX Annual reports of TFX
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.